3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
pembrolizumab
17
Bevacizumab
12
Standard of Care
10
Cyclophosphamide
9
Carboplatin
9
Doxorubicin
7
Cetuximab
7
Nivolumab
6
Exercise
6
olaparib
5
atezolizumab
5
Rituximab
5
Radiotherapy
5
Pemetrexed
5
Fluorouracil
5
Cisplatin
5
durvalumab
4
dostarlimab
4
abemaciclib
4
Temozolomide
4
Prednisone
4
Paclitaxel
4
Leucovorin
4
Blood Specimen Collection
4
venetoclax
3
temsirolimus
3
talazoparib
3
pertuzumab
3
obinutuzumab
3
ibrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Maintenance
×
30 days
×
Clear all
No trials found.